drugset / Trial / NCT07089823
A Study of YP05002 in Healthy Participants
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, efficacy, food effect of YP05002 Tablets in healthy participants
Timeline
- Start
- 2025-08-19
- Primary completion
- 2026-04-12
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | YP05002 | Unknown | — | — |
Indications
No indication recorded.